Alaunos Therapeutics
TCRT
85 hedge funds and large institutions have $233M invested in Alaunos Therapeutics in 2014 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 30 increasing their positions, 23 reducing their positions, and 20 closing their positions.
84% more capital invested
Capital invested by funds: $126M → $233M (+$106M)
78% more call options, than puts
Call options by funds: $7.84M | Put options by funds: $4.4M
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
30% more repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 23
10% less funds holding
Funds holding: 94 → 85 (-9)
30% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 20
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MP
MSD Partners
New York
|
+$4.85M |
| 2 |
BGA
Belmont Global Advisors
Dallas,
Texas
|
+$2.31M |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$1.09M |
| 4 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
+$933K |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$827K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$8.28M |
| 2 |
Jennison Associates
New York
|
-$4.01M |
| 3 |
Renaissance Technologies
New York
|
-$708K |
| 4 |
RA
Royce & Associates
New York
|
-$708K |
| 5 |
Group One Trading
Chicago,
Illinois
|
-$416K |
TCRT Hedge Fund Activity: Q4 2014 in Review
85 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Alaunos Therapeutics (TCRT) for Q4 2014, worth a combined $233M — up 84% from $126M a quarter earlier.
Sellers outnumbered buyers: 20 funds closed out of TCRT and 14 opened new positions — a net loss of 6 holders — while 23 trimmed existing stakes and 30 added.
The largest buyer was MSD Partners, adding an estimated $4.85M. The largest seller was Fidelity Investments, exiting entirely with an estimated $8.28M sold.
- 85 institutional investors held Alaunos Therapeutics (TCRT) as of Q4 2014, down from 94 in Q3 2014.
- Funds reported $233M of Alaunos Therapeutics stock for Q4 2014, up 84% quarter-over-quarter.
- 14 funds opened new Alaunos Therapeutics positions in Q4 2014 and 20 closed out, a net change of -6 holders.
- The largest Alaunos Therapeutics buyer in Q4 2014 was MSD Partners, an estimated $4.85M added.
- The largest Alaunos Therapeutics seller in Q4 2014 was Fidelity Investments, an estimated $8.28M sold.
Based on aggregated 13F filings for Q4 2014.